This study is a Delphi-based expert consensus project aimed at developing evidence-informed recommendations for the safe and effective use of nutriceuticals during pregnancy. Despite widespread use of vitamins, minerals, and other dietary supplements in prenatal care, significant variability exists in clinical practice regarding indications, dosing, timing, and safety monitoring.
Eligibility
Sex
ALL
Min age
25 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Board-certified obstetricians, maternal-fetal medicine specialists, or clinical nutritionists with ≥5 years of relevant clinical experience.
Active involvement in prenatal care and experience or knowledge in nutriceutical use during pregnancy.
Engagement in clinical teaching, research, guideline development, or professional society activities related to maternal health or nutrition.
Willingness and availability to participate in all Delphi rounds.
Provision of informed consent to participate.
Exclusion Criteria:
* Non-obstetric or non-nutrition specialty.
Less than 5 years of relevant clinical experience.
Limited or no experience with nutriceutical counseling/prescribing in pregnancy.
Significant undisclosed conflict of interest related to nutriceutical products.
Inability or unwillingness to participate in all Delphi rounds.
Primary outcome measure(s)
Primary Outcome — 6-12 weeks Level of expert consensus on statements regarding nutraceutical use in pregnancy, measured as the proportion of panelists reaching the predefined agreement threshold (e.g., ≥70-80%) for each statement across Delphi rounds.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.